FR Doc E8-1241 [Federal Register: January 25, 2008 (Volume
73, Number 17)] [ Notices] [Page 4630-4633] From the Federal
Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25ja08-125]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Nasim F. Khan, M.D.; Denial of Application
On June 8, 2007, the Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement Administration, issued an
Order to Show Cause to Nasim F. Khan, M.D. (Respondent), of
Houston, Texas. The Show Cause Order proposed the denial of
Respondent's pending application for a DEA Certificate of
Registration as a practitioner on two grounds: (1) That she
lacked authority under state law to handle controlled
substances, and (2) that her "registration would be inconsistent
with the public interest.'' Show Cause Order at 1; see also 21
U.S.C. 823(f).
The Show Cause Order specifically alleged that "[o]n June 26,
2006, [Respondent's] Texas Controlled Substance Registration was
terminated,'' and that she was therefore "not currently
authorized by the State of Texas to prescribe, dispense, or
otherwise handle controlled substances.'' Show Cause Order at 1.
The Show Cause Order further alleged that Respondent had
committed acts inconsistent with the public interest because she
had "allowed [her] DEA registration to be used to dispense
controlled substances for other than legitimate medical
purposes'' and had "engage[ed] in self-prescribing of controlled
substances, in violation of the Texas Controlled Substances
Act.'' Id.
On June 15, 2007, the Show Cause Order, which also notified
Respondent of her right to request a hearing on the allegations,
was served on Respondent by Federal Express delivered to her
residence. Because: (1) More than thirty days have passed since
service of the Show Cause Order, and (2) neither Respondent, nor
anyone purporting to represent her, has requested a hearing, I
conclude that Respondent has waived her right to a hearing. See 21
CFR 1301.43(d). I therefore enter this Final Order without a
hearing based on relevant material contained in the
[[Page 4631]]
investigative file, see id. 1301.43(e), and make the
following findings.
Findings
Respondent is a physician with a specialty in psychiatry and
pathology. Respondent previously held a DEA Certificate of
Registration as a practitioner at the registered location of
Houston Medical Clinic, 10881 Richmond Ave., Apt. 412, Houston,
Texas. In July 2004, DEA Diversion Investigators with the
Houston Field Division received information that Respondent was
prescribing promethazine with codeine cough syrup, a schedule V
controlled substance, see 21
CRR 1308.15(c), to an individual who had been arrested three
times by the Houston Police Department for unlawfully possessing
controlled substances.
In August 2005, DEA Diversion Investigators (DIs) received
information that two unlicensed individuals (F.K. and V.V.), who
worked at the Main Medical Clinic (which was located in Jacinto
City, Texas), were using Respondent's DEA registration to issue
controlled-substance prescriptions for drugs which included
Lorcet 10/650 (a branded drug combining hydrocodone and
acetaminophen and a schedule III controlled substance, see 21
CFR 1308.13(e), Xanax (alprazolam), a schedule IV controlled
substance, see id. 1308.14(c), and promethazine with codeine
cough syrup. Id. 1308.15(c). F.K. and V.V. charged $100 for each
prescription.
The DIs subsequently went to the clinic and interviewed
several people. While the DIs were told that Respondent had
terminated her employment at the clinic, they also obtained a
stack of prescription carbons. The copies indicated the
patient's name, the name of a controlled substance, and
Respondent's DEA number. During other interviews, the DIs
determined that Respondent had seen only one or two "patients''
each day, and that most of the clinic's "patients'' were seen by
other people including several foreign graduate students who
were not licensed in any field of medical practice. The DIs also
confirmed that V.V. had sold a stack of prescriptions, which
bore a signature similar to Respondent's, for a large amount of
cash.
Thereafter, on August 11, 2005, the DIs interviewed
Respondent at the location of a clinic (named the "45 Clinic'')
which she was opening in Houston and for which she needed to
change the address of her registered location.\1\ During the
interview, Respondent stated that she had seen approximately
forty patients a day at the Main Medical Clinic and that the
cost for a controlled-substance prescription was $80 cash.
Respondent further stated that at the clinic, foreign graduate
students worked under her supervision and wrote the
prescriptions which she then signed. Respondent also stated that
she had taken a continuing medical education class in pain
management and that the only controlled substances she
prescribed were Vicodin, Lorcet, and Lortab.\2\
---------------------------------------------------------------------------
\1\ According to the investigative file,
Respondent did not own the clinic.
\2\ Respondent also stated that she
prescribed Ritalin for her child psychiatric patients who had
Attention Deficit Disorder.
---------------------------------------------------------------------------
In the course of the investigation, the DIs had previously
determined that Respondent had obtained controlled substances
based on 117 prescriptions issued to her under her DEA number.
During the interview, Respondent denied that she had
self-prescribed and claimed that her son was also a physician
and had prescribed the controlled substances for her.
Subsequently, the DIs searched the Texas Medical Board's website
and found that there was no listing for her son. The DIs had
also previously determined that between January 1, 2004, and
August 11, 2005, Respondent had obtained approximately 474
twenty-five ml. bottles of schedule V cough medicines. When
asked as to why she had ordered the drugs, Respondent maintained
that they were small containers of cough syrup which she used
when she was unable to sleep.
While at Respondent's new clinic, the DIs interviewed V.V.,
the same individual who had been implicated in selling
controlled-substance prescriptions at Respondent's former
employer. V.V. told the investigators that she had first met
Respondent on that very day (when she had purportedly
interviewed for a position at the clinic) and that her duties at
Respondent's clinic would include scheduling appointments,
taking vital signs, and other duties performed by receptionists.
Thereafter, on August 30, 2005, a registration technician
changed Respondent's registered location to the address of her
new clinic. Approximately three weeks later, on September 19,
2005, Respondent notified a DI that V.V. was using her DEA
number to write unauthorized prescriptions for unknown
individuals.
Later that day, two DIs interviewed Respondent at her
residence. Respondent told the DIs that she had terminated her
employment at the Main Medical Clinic because she suspected that
its owner was involved in illegal activities. Respondent stated
that she had contacted DEA because she had received information
that the Corpus Christi, Texas Police Department was looking for
her regarding prescriptions she had written. Respondent further
stated that during the previous week, she had gone to her new
clinic and attempted to retrieve her prescriptions but was told
that the pads belonged to the clinic. Respondent added that she
had become concerned that someone was using her DEA number to
issue prescriptions without her consent. Because of the
unauthorized use of her number, Respondent then agreed to
voluntarily surrender her DEA registration. She also surrendered
her state controlled-substances registration.
On September 30, 2005, Respondent applied for a new
registration using the address of the 45 Clinic for her proposed
registered location. Several days later, two DIs went to
Respondent's residence and attempted to interview her. Upon
opening the door, Respondent started screaming at the DIs and
stated that they should contact her attorney. When one of the
DIs asked Respondent for her attorney's phone number, Respondent
stated that she would get the number and slammed the door.
Several minutes later, Respondent opened the door, threw a piece
of paper at the DI, and stated in a loud voice that "the White
House knew who her father was and that she was his daughter.''
After the DIs told Respondent that they were there to speak to
her about her application, Respondent stated that "there would
be no trick or treating here today.'' One of the DIs again asked
Respondent whether she had applied for a new registration.
Respondent answered "yes'' and again slammed the door shut.
Thereafter, a local pharmacist notified DEA investigators
that on October 3 and 4, he had received two prescriptions which
were written under Respondent's DEA number. The pharmacist told
the DIs that when he had attempted to verify one the
prescriptions, Respondent did not return the call. Respondent,
in a subsequent interview, denied issuing the prescriptions.
On January 5, 2006, a detective with the Garland, Texas
Police Department notified one of the DIs that numerous
prescriptions written under Respondent's former DEA registration
had been presented at a local pharmacy. The prescriptions bore
the name and address of the Main Medical Clinic, Respondent's
former employer.
[[Page 4632]]
Thereafter, on March 28, 2006, an official of the Texas
Department of Public Safety (DPS) notified a DI that the State
intended to terminate Respondent's state controlled-substances
registration. The state official further told the DI that
Respondent's application had been erroneously granted because at
the time the application was approved, the State was upgrading
its computer system and was unable to access her history.
Subsequently, on June 26, 2006, DPS terminated Respondent's
state controlled-substances registration on the ground that she
was prohibited under the State's rules for re-applying for a
period of one year following her surrendering of her state
registration. I further find that the State has not re-instated
her controlled-substances registration.
I also find that on August 24, 2007, Respondent entered into
an Agreed Order with the Texas Medical Board. Under the order,
Respondent voluntarily and permanently surrendered her medical
license. According to the Texas Medical Board's website, "[t]he
action was based on [Respondent's] failure to meet the standard
of care due [to] her non- therapeutic prescription of controlled
substances to four patients and to herself.''
Discussion
Section 303(f) of the Controlled Substances Act provides that
"[t]he Attorney General shall register practitioners * * * to
dispense * * * controlled substances in schedule II, III, IV, or
V, if the applicant is authorized to dispense * * * controlled
substances under the laws of the State in which he practices.'' 21
U.S.C. 823(f). Section 303(f) further provides that "[t]he
Attorney General may deny an application for such registration
if he determines that the issuance of such registration would be
inconsistent with the public interest.'' Id. In making the
public interest determination, the Act requires the
consideration of the following factors:
(1) The recommendation of the appropriate State licensing
board or professional disciplinary authority.
(2) The applicant's experience in dispensing * * *
controlled substances.
(3) The applicant's conviction record under Federal or
State laws relating to the manufacture, distribution, or
dispensing of controlled substances.
(4) Compliance with applicable State, Federal, or local
laws relating to controlled substances.
(5) Such other conduct which may threaten the public health
and safety.
Id.
"[T]hese factors are * * * considered in the disjunctive.''
Robert A. Leslie, M.D., 68 FR 15227, 15230 (2003). I "may rely
on any one or a combination of factors, and may give each factor
the weight [I] deem[] appropriate in determining whether a
registration should be revoked.'' Id. Moreover, I am "not
required to make findings as to all of the factors.'' Hoxie v.
DEA, 419 F.3d 477, 482 (6th Cir. 2005); see also Morall v. DEA,
412 F.3d 165, 173-74 (DC Cir. 2005).
In this case, I conclude that there are two independent
grounds for denying Respondent's application. First, Respondent
is not currently authorized under Texas law to handle controlled
substances and thus does not meet an essential requirement for a
registration under the CSA. Second, while it appears that
Respondent will not be returning to medical practice anytime
soon, her experience in dispensing controlled substances and her
record of compliance with applicable laws make clear that
granting her a registration "would be inconsistent with the
public interest.'' 21
U.S.C. 823(f).
Under the Controlled Substances Act (CSA), a practitioner
must be currently authorized to handle controlled substances in "the
jurisdiction in which [she] practices'' in order to maintain a
DEA registration. See 21
U.S.C. 802(21) ("[t]he term `practitioner' means a physician
* * * licensed, registered, or otherwise permitted, by * * * the
jurisdiction in which he practices * * * to distribute,
dispense, [or] administer * * * a controlled substance in the
course of professional practice''). See also id. section 823(f)
("The Attorney General shall register practitioners * * * if the
applicant is authorized to dispense * * * controlled substances
under the laws of the State in which he practices.''). Relatedly,
DEA has repeatedly held that the CSA requires the revocation of
a registration issued to a practitioner who no longer possesses
authority under state law to handle controlled substances. See
Sheran Arden Yeates, 71 FR 39130, 39131 (2006); Dominick A.
Ricci, 58 FR 51104, 51105 (1993); Bobby Watts, 53 FR 11919,
11920 (1988). See also 21
U.S.C. 824(a)(3) (authorizing the revocation of a
registration "upon a finding that the registrant * * * has had
his State license or registration suspended [or] revoked * * *
and is no longer authorized by State law to engage in the * * *
distribution [or] dispensing of controlled substances'').
Here, the investigative file establishes that Respondent's
Texas controlled-substances registration was terminated on June
26, 2006. Moreover, there is no evidence that the State has
issued a new controlled substance registration to her, and the
Agreed Order which Respondent entered into with the Texas
Medical Board suggests that the State will not grant her a new
controlled-substances registration any time soon. Because
Respondent is without authority to handle controlled substances
in Texas, the State in which she seeks a DEA registration, she
does not meet an essential prerequisite for a new DEA
registration. Accordingly, her application is denied on that
basis. See 21
U.S.C. 823(f).
I further note that even if Respondent possessed a state
registration, the record would still support the denial of her
application on the ground that her registration would be "inconsistent
with the public interest.'' 21 U.S.C. 823(f). As the State
found, Respondent has engaged in the non-therapeutic
prescription of controlled substances both to herself and
others.
With respect to her self-prescribing, the record establishes
that Respondent issued to herself 117 prescriptions for
narcotic-cough syrups, which are schedule V controlled
substances. The record further establishes that Respondent's
statements to investigators that the prescriptions were issued
to her by her son, and that her son was a physician, were false.
Moreover, there is also substantial and disturbing evidence
that Respondent failed to exercise proper control over her
prescriptions pads and allowed unlicensed and un-registered
individuals at the Main Medical Clinic to write prescriptions
under her DEA registration. This conduct violates federal law
and regulations, which require that a prescription be "issued
for a legitimate medical purpose by an individual practitioner
acting in the usual course of [her] professional practice,'' 21
CFR 1306.04(a), and that each person writing a prescription
be "[a]uthorized to prescribe controlled substances by the
jurisdiction in which he is licensed to practice his profession
and * * * [e]ither registered or exempted from registration.''
Id. Sec.
1306.03(a). Accordingly, even if Respondent held a state
registration, her abysmal experience in dispensing controlled
substances and her record of non-compliance with federal and
state laws related to controlled substances would nonetheless
require the denial of her application.
Order
Pursuant to the authority vested in me by 21
U.S.C. 823(f), as well as 28 CFR 0.100(b) & 0.104, I
order that the application of Nasim F. Khan, M.D., for
[[Page 4633]]
a DEA Certificate of Registration as a practitioner be, and
it hereby is, denied. This order is effective February 25, 2008.
Dated: January 17, 2008.
Michele M. Leonhart,
Deputy Administrator.
[FR Doc. E8-1241 Filed 1-24-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).